Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

MORPHINE SULFATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for morphine sulfate and what is the scope of morphine sulfate patent protection?

Morphine sulfate
is the generic ingredient in twelve branded drugs marketed by Novel Labs Inc, Egalet, Upsher Smith, Dava Pharms Inc, West-ward Pharms Int, Hospira, Vintage Pharms Llc, Impax Labs Inc, Nostrum Labs Inc, Par Pharm Inc, Mallinckrodt, Hospira Inc, Allergan Sales Llc, Icu Medcl, Purdue Pharma Lp, Lannett Holdings Inc, Teva Pharms Usa, Tris Pharma Inc, Rhodes Pharms, Nesher Pharms, Fresenius Kabi Usa, Mylan Pharms Inc, Mallinckrodt Inc, Sun Pharm Inds, Actavis Elizabeth, Daiichi Sankyo Inc, Vistapharm, Watson Labs, Corepharma, Eurohlth Intl Sarl, King Pharms Llc, Sun Pharm Inds Ltd, Pacira Pharms Inc, Pharm Assoc, Paddock Llc, Xanodyne Pharms Inc, Mayne Pharma Inc, Meridian Medcl Techn, and Alpharma Pharms, and is included in sixty-four NDAs. There are twenty-three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Morphine sulfate has ninety-three patent family members in twenty countries.

There are twenty-three drug master file entries for morphine sulfate. Fifty-four suppliers are listed for this compound.

Summary for Generic Name: MORPHINE SULFATE

Drug Master File Entries: see list23
Suppliers / Packagers: see list54
Bulk Api Vendors: see list16
Clinical Trials: see list706
Patent Applications: see list9,862
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:MORPHINE SULFATE at DailyMed

Pharmacology for Ingredient: MORPHINE SULFATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Pharms
morphine sulfate; naltrexone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009RXYesNo8,623,418► Subscribe ► Subscribe
Daiichi Sankyo Inc
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL206544-003Oct 2, 2015RXYesNo7,955,619► SubscribeY ► Subscribe
West-ward Pharms Int
morphine sulfate
INJECTABLE;INJECTION018565-002Sep 18, 1984APRXYesYes► Subscribe► Subscribe
Upsher Smith
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL202104-005Jun 3, 2013ABRXNoNo► Subscribe► Subscribe
Alpharma Pharms
morphine sulfate; naltrexone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009RXYesNo8,158,156► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus